NATALIE RODRIGUEZ: Open Payments
NPI 1033886809 · BENTON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 22 payments from 10 companies in 2025. Trend: 2023 $306 · 2024 $448 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 7 | $203 |
| Phathom Pharmaceuticals, Inc. | 3 | $137 |
| Novo Nordisk Inc | 1 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Abbott Laboratories | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| ABBVIE INC. | 1 | $23 |
| Exact Sciences Corporation | 1 | $20 |
| PFIZER INC. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: Qelbree, VOQUEZNA, Wegovy, CAPLYTA, FREESTYLE LIBRE 3, UBRELVY, BREZTRI, AIRSUPRA.
Industry payments across AR — which companies pay providers there.
